LIVIVO - Search results -

Search results

Result 1 - 10 of total 8604

Search options

Article: COVID-19 and the kidney.

Canpolat, Nur

Turkish archives of pediatrics

2021 Volume 56, Issue 2, Page(s) 97–98

Language	English
Publishing date	2021-02-03
Document type	Editorial
ISSN	2757-6256
ISSN	2757-6256
DOI	10.5152/TurkArchPediatr.2021.150121
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: COVID-19 and the kidney.

Hassanein, Mohamed / Radhakrishnan, Yeshwanter / Sedor, John / Vachharajani, Tushar / Vachharajani, Vidula T / Augustine, Joshua / Demirjian, Sevag / Thomas, George

Cleveland Clinic journal of medicine

2020 Volume 87, Issue 10, Page(s) 619–631

Abstract: ... its optimal management, and the impact of COVID-19 on patients with chronic kidney disease, patients ... COVID-19 is primarily considered a respiratory illness, but the kidney may be one of the targets ... which is found in abundance in the kidney. Information on kidney involvement in COVID-19 is limited but is ...

Abstract	COVID-19 is primarily considered a respiratory illness, but the kidney may be one of the targets of SARS-CoV-2 infection, since the virus enters cells through the angiotensin-converting enzyme 2 receptor, which is found in abundance in the kidney. Information on kidney involvement in COVID-19 is limited but is evolving rapidly. This article discusses the pathogenesis of acute kidney injury (AKI) in COVID-19, its optimal management, and the impact of COVID-19 on patients with chronic kidney disease, patients with end-stage kidney disease on dialysis, and kidney transplant recipients.
MeSH term(s)	Angiotensin-Converting Enzyme 2 ; Betacoronavirus/physiology ; COVID-19 ; Comorbidity ; Coronavirus Infections/epidemiology ; Coronavirus Infections/physiopathology ; Coronavirus Infections/virology ; Cost of Illness ; Humans ; Kidney Diseases/classification ; Kidney Diseases/epidemiology ; Kidney Diseases/therapy ; Kidney Diseases/virology ; Pandemics ; Patient Care Management/methods ; Peptidyl-Dipeptidase A/metabolism ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/physiopathology ; Pneumonia, Viral/virology ; SARS-CoV-2
Chemical Substances	Peptidyl-Dipeptidase A (EC 3.4.15.1) ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23)
Keywords	covid19
Language	English
Publishing date	2020-10-01
Publishing country	United States
Document type	Journal Article ; Review
ZDB-ID	639116-3
ISSN	1939-2869 ; 0891-1150
ISSN (online)	1939-2869
ISSN	0891-1150
DOI	10.3949/ccjm.87a.20072
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.212: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: COVID-19 and the Kidney

Luis Sanchez-Russo / Marzuq Billah / Jorge Chancay / Judy Hindi / Paolo Cravedi

Journal of Clinical Medicine, Vol 10, Iss 5, p

A Worrisome Scenario of Acute and Chronic Consequences

2021 Volume 900

Abstract: ... and has been associated with higher rates of death when compared to COVID-19 patients without kidney ... Acute kidney injury (AKI) is a common finding in patients with coronavirus disease 2019 (COVID-19 ... will remain dependent on kidney replacement therapy. Nephrologists and healthcare workers need to be familiar ...

Abstract	Acute kidney injury (AKI) is a common finding in patients with coronavirus disease 2019 (COVID-19) and has been associated with higher rates of death when compared to COVID-19 patients without kidney injury. Whereas the definitive pathogenesis of COVID-19-related AKI (CoV-AKI) is not clear, histopathologic evidence seems to point at multiple etiologies for the disease, including indirect and direct viral kidney injury. The high incidence of CoV-AKI, along with the aggressive clinical presentation of this entity, have increased the demands for kidney replacement therapies, rapidly overwhelming the supplies of healthcare systems even in major tertiary care centers. As a result, nephrologists have come up with alternatives to maximize the efficiency of treatments and have developed non-conventional therapeutic alternatives such as the implementation of acute peritoneal dialysis for critically ill patients. The long-term implications of CoV-AKI are yet unknown, though early studies suggest that around one third of the patients who survive will remain dependent on kidney replacement therapy. Nephrologists and healthcare workers need to be familiar with the clinical presentation and therapeutic challenges of CoV-AKI in order to develop strategies to mitigate the burden of the disease for patients, and for services providing kidney replacement therapies.
Keywords	AKI ; CKD ; COVID-19 ; CG ; CoV-AKI ; ATI ; Medicine ; R
Subject code	610
Language	English
Publishing date	2021-02-01T00:00:00Z
Publisher	MDPI AG
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: COVID-19 and the kidney

Anna Laura Herzog / Holger K von Jouanne-Diedrich / Christoph Wanner / Dirk Weismann / Tobias Schlesinger / Patrick Meybohm / Jan Stumpner

PLoS ONE, Vol 16, Iss 5, p e

A retrospective analysis of 37 critically ill patients using machine learning.

2021 Volume 0251932

Abstract: ... of kidney failure, the development of chronic kidney disease, and mortality in 37 critically ill COVID-19 ... Introduction There is evidence that SARS-CoV2 has a particular affinity for kidney tissue and is ... identified highly predictive variables for outcome and remaining chronic kidney disease. Conclusions ...

Abstract	Introduction There is evidence that SARS-CoV2 has a particular affinity for kidney tissue and is often associated with kidney failure. Methods We assessed whether proteinuria can be predictive of kidney failure, the development of chronic kidney disease, and mortality in 37 critically ill COVID-19 patients. We used machine learning (ML) methods as decision trees and cut-off points created by the OneR package to add new aspects, even in smaller cohorts. Results Among a total of 37 patients, 24 suffered higher-grade renal failure, 20 of whom required kidney replacement therapy. More than 40% of patients remained on hemodialysis after intensive care unit discharge or died (27%). Due to frequent anuria proteinuria measured in two-thirds of the patients, it was not predictive for the investigated endpoints; albuminuria was higher in patients with AKI 3, but the difference was not significant. ML found cut-off points of >31.4 kg/m2 for BMI and >69 years for age, constructed decision trees with great accuracy, and identified highly predictive variables for outcome and remaining chronic kidney disease. Conclusions Different ML methods and their clinical application, especially decision trees, can provide valuable support for clinical decisions. Presence of proteinuria was not predictive of CKD or AKI and should be confirmed in a larger cohort.
Keywords	Medicine ; R ; Science ; Q
Subject code	616
Language	English
Publishing date	2021-01-01T00:00:00Z
Publisher	Public Library of Science (PLoS)
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: COVID-19 and Acute Kidney Injury.

Hilton, James / Boyer, Naomi / Nadim, Mitra K / Forni, Lui G / Kellum, John A

Critical care clinics

2022 Volume 38, Issue 3, Page(s) 473–489

Abstract: Initial reporting suggested that kidney involvement following COVID-19 infection was uncommon ... with an increased risk for both morbidity and death. Mechanisms of injury include direct kidney damage predominantly ... The mainstay of treatment remains the prevention of worsening kidney damage and in some cases they need ...

Abstract	Initial reporting suggested that kidney involvement following COVID-19 infection was uncommon but this is now known not to be the case. Acute kidney injury (AKI) may arise through several mechanisms and complicate up to a quarter of patients hospitalized with COVID-19 infection being associated with an increased risk for both morbidity and death. Mechanisms of injury include direct kidney damage predominantly through tubular injury, although glomerular injury has been reported; the consequences of the treatment of patients with severe hypoxic respiratory failure; secondary infection; and exposure to nephrotoxic drugs. The mainstay of treatment remains the prevention of worsening kidney damage and in some cases they need for renal replacement therapies (RRT). Although the use of other blood purification techniques has been proposed as potential treatments, results to-date have not been definitive.
MeSH term(s)	Acute Kidney Injury/etiology ; Acute Kidney Injury/therapy ; COVID-19/complications ; COVID-19/therapy ; Humans ; Renal Replacement Therapy ; SARS-CoV-2
Language	English
Publishing date	2022-01-10
Publishing country	United States
Document type	Journal Article ; Review
ZDB-ID	1006423-0
ISSN	1557-8232 ; 0749-0704
ISSN (online)	1557-8232
ISSN	0749-0704
DOI	10.1016/j.ccc.2022.01.002
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Se 990: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article: COVID-19 and chronic kidney disease.

Treviño-Becerra, Alejandro / Grajales-García, Dulce P / Feria-Ramirez, José A

Gaceta medica de Mexico

2022 Volume 158, Issue 4, Page(s) 179–181

Title translation	COVID-19 y enfermedad renal crónica.
MeSH term(s)	Humans ; COVID-19 ; SARS-CoV-2 ; Renal Insufficiency, Chronic/complications
Language	English
Publishing date	2022-10-18
Publishing country	Mexico
Document type	Journal Article
ZDB-ID	425456-9
ISSN	0016-3813
ISSN	0016-3813
DOI	10.24875/GMM.M22000676
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.38: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Long-term interplay between COVID-19 and chronic kidney disease.

Schiffl, Helmut / Lang, Susanne M

International urology and nephrology

2023 Volume 55, Issue 8, Page(s) 1977–1984

Abstract: ... on-chronic kidney damage), and death. Patients who have survived COVID-19 face an increased risk of worse ... Results: There is a bidirectional relationship between chronic kidney disease and COVID-19 disease ... Purpose: The COVID-19 pandemic may have an impact on the long-term kidney function of survivors ...

Abstract	Purpose: The COVID-19 pandemic may have an impact on the long-term kidney function of survivors. The clinical relevance is not clear. Methods: This review summarises the currently published data. Results: There is a bidirectional relationship between chronic kidney disease and COVID-19 disease. Chronic kidney diseases due to primary kidney disease or chronic conditions affecting kidneys increase the susceptibility to COVID-19 infection, the risks for progression and critical COVID-19 disease (with acute or acute-on-chronic kidney damage), and death. Patients who have survived COVID-19 face an increased risk of worse kidney outcomes in the post-acute phase of the disease. Of clinical significance, COVID-19 may predispose surviving patients to chronic kidney disease, independently of clinically apparent acute kidney injury (AKI). The increased risk of post-acute renal dysfunction of COVID-19 patients can be graded according to the severity of the acute infection (non-hospitalised, hospitalised or ICU patients). The burden of chronic kidney disease developing after COVID-19 is currently unknown. Conclusion: Post-acute COVID-19 care should include close attention to kidney function. Future prospective large-scale studies are needed with long and complete follow-up periods, assessing kidney function using novel markers of kidney function/damage, urinalysis and biopsy studies.
MeSH term(s)	Humans ; Pandemics ; COVID-19/complications ; Renal Insufficiency, Chronic/complications ; Kidney ; Prospective Studies ; Acute Kidney Injury/epidemiology ; Acute Kidney Injury/etiology ; Retrospective Studies
Language	English
Publishing date	2023-02-24
Publishing country	Netherlands
Document type	Journal Article ; Review
ZDB-ID	204048-7
ISSN	1573-2584 ; 0301-1623 ; 0042-1162
ISSN (online)	1573-2584
ISSN	0301-1623 ; 0042-1162
DOI	10.1007/s11255-023-03528-x
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 733: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article: COVID-19 and chronic kidney disease: a bibliometric analysis.

Jiang, Wenze / Chen, Yuting / Zhao, Yuxin / Gao, Yang / Cheng, Tianyang / Qian, Enhui / Hou, Yating / Lu, Keda

Annals of medicine and surgery (2012)

2023 Volume 86, Issue 1, Page(s) 336–344

Abstract: Background: The COVID-19 pandemic has caused over 656 million confirmed cases and over 6.6 million ... deaths worldwide. Chronic kidney disease (CKD) is considered a high-risk factor for COVID-19 ... a bibliometric analysis of publications related to COVID-19 and CKD.: Methods: Publications were retrieved from the Web ...

Abstract	Background: The COVID-19 pandemic has caused over 656 million confirmed cases and over 6.6 million deaths worldwide. Chronic kidney disease (CKD) is considered a high-risk factor for COVID-19; therefore, considerable research has been conducted in this field. Therefore, this study aims to conduct a bibliometric analysis of publications related to COVID-19 and CKD. Methods: Publications were retrieved from the Web of Science Core Collection database on 16 January 2023 and screened based on inclusion criteria. Then the authors used Microsoft Excel and CiteSpace to analyze the included publications from the following seven aspects: countries/regions, institutions, journals, authors, cited references, and keywords. Results: In total, 622 publications were included in the study. The USA has the most publications in this field, followed by China. The Icahn School of Medicine at Mount Sinai and Harvard Medical School had the highest number of publications in the field. Journal of Clinical Medicine had the largest number of publications, and Lancet was the most cited journal. Alberto Ortiz was the author with the largest number of publications, but there were no influential authors in this field. The highly cited references are mainly clinical studies on COVID-19. Research hotspots in this field include end-stage recent disease, cardiovascular disease, kidney metastasis, diabetes Mellitus, acute kidney injury, meta-analysis, and consistent plasma. Conclusions: The USA, China, and some European countries and their institutions are major contributors to these publications. End-stage renal disease, acute kidney injury, kidney transplantation and convalescent plasma are current hot topics in the field.
Language	English
Publishing date	2023-12-19
Publishing country	England
Document type	Journal Article ; Review
ZDB-ID	2745440-X
ISSN	2049-0801
ISSN	2049-0801
DOI	10.1097/MS9.0000000000001640
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function.

Seethapathy, Rituvanthikaa / Wang, Qiyu / Zhao, Sophia / Strohbehn, Ian A / Long, Joshua D / Dinulos, James E / Harden, Destiny / Kadiyala, Vinay B / Moreno, Daiana / Sise, Meghan E

PloS one

2023 Volume 18, Issue 2, Page(s) e0279765

Abstract: Background: Chronic kidney disease (CKD) is an important risk factor for mortality from COVID-19 ... incidence of doubling of creatinine (10.3% vs. 13.1%, P = 0.48), and rate of kidney ... Remdesivir has been shown to shorten time to recovery in patients with severe COVID-19. However, exclusion ...

Abstract	Background: Chronic kidney disease (CKD) is an important risk factor for mortality from COVID-19. Remdesivir has been shown to shorten time to recovery in patients with severe COVID-19. However, exclusion of patients with severe kidney function impairment in clinical trials has led to concerns about kidney safety of remdesivir in patients with pre-existing kidney disease. Methods: Retrospective propensity score matched cohort study of hospitalized patients with COVID-19 admitted with estimated glomerular filtration rate (eGFR) between 15 - 60 mL/min/1.73m2. Remdesivir-treated patients were 1:1 matched to historical comparators admitted during the first wave of COVID-19 (between March-April 2020) prior to emergency use authorization of remdesivir using propensity scores accounting for factors predicting treatment assignment. Dependent outcomes included in-hospital peak creatinine, incidence of doubling of creatine, rate of kidney replacement therapy initiation and eGFR among surviving patients at day 90. Results: 175 remdesivir-treated patients were 1:1 matched to untreated historical comparators. Mean age was 74.1 (SD 12.8), 56.9% were male, 59% patients were white, and the majority (83.1%) had at least one co-morbidity. There were no statistically significant differences in peak creatinine during hospitalization (2.3mg/dL vs. 2.5 mg/dL, P = 0.34), incidence of doubling of creatinine (10.3% vs. 13.1%, P = 0.48), and rate of kidney replacement therapy initiation (4.6% vs. 6.3%, P = 0.49) in remdesivir-treated patients versus matched untreated historical comparators, respectively. Among surviving patients, there was no difference of the average eGFR at day 90 (54.7 ± 20.0 mL/min/1.73m2 for remdesivir-treated patients vs. 51.7 ± 19.5 mL/min/1.73m2 for untreated comparators, P = 0.41). Conclusions: Remdesivir use in patients with impaired kidney function (eGFR between 15 - 60 mL/min/1.73m2) who present to the hospital with COVID-19 is not associated with increased risk of adverse kidney outcomes.
MeSH term(s)	Humans ; Male ; Female ; Aged ; Cohort Studies ; Creatinine ; Retrospective Studies ; COVID-19 ; COVID-19 Drug Treatment ; Kidney ; Renal Insufficiency
Chemical Substances	remdesivir (3QKI37EEHE) ; Creatinine (AYI8EX34EU)
Language	English
Publishing date	2023-02-27
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2267670-3
ISSN	1932-6203 ; 1932-6203
ISSN (online)	1932-6203
ISSN	1932-6203
DOI	10.1371/journal.pone.0279765
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Severe COVID-19 and chronic kidney disease: bidirectional mendelian randomization study.

Lin, Haishan / Cao, Bangwei

Virology journal

2024 Volume 21, Issue 1, Page(s) 32

Abstract: Traditional observational research has revealed an association between severe COVID-19 and ... for personalized risk assessment and targeted interventions to mitigate the effects of COVID-19 on individuals ... with CKD. Using combined data from a GWAS on European ancestry and CKD (n = 117,165) and critical COVID-19 ...

Abstract	Traditional observational research has revealed an association between severe COVID-19 and chronic kidney disease (CKD). It is unclear whether there is a causative connection between them. Our goal was to determine whether genetically predicted CKD is associated with the risk of critical COVID-19. We aimed to investigate potential underlying genetic mechanisms that could explain this relationship, paving the way for personalized risk assessment and targeted interventions to mitigate the effects of COVID-19 on individuals with CKD. Using combined data from a GWAS on European ancestry and CKD (n = 117,165) and critical COVID-19 (n = 1,059,456), bidirectional Mendelian randomization analysis was performed. Four single nucleotide polymorphisms (SNPs) were chosen from the genome as CKD instrumental variables (IVs). In addition to MR‒Egger regression, weighted mode approaches, and weighted medians, we employed the inverse-variance weighted estimate as our primary analytical method. A significant association of CKD with critical COVID-19 (OR = 1.28, 95% confidence interval [CI]: 1.04-1.58, p = 0.01811) was found. However, using 6 genome-wide significant SNPs as IVs for critical COVID-19, we could not discover a meaningful correlation between severe COVID-19 and CKD (OR = 1.03, 95% CI: 0.96-1.10, p = 0.3947). We found evidence to support a causal relationship between CKD and severe COVID-19 in European population. This underscores the need for comprehensive monitoring and specialized care strategies for individuals with CKD to mitigate the heightened risk and severity of COVID-19 complications.
MeSH term(s)	Humans ; COVID-19/epidemiology ; Mendelian Randomization Analysis ; Polymorphism, Single Nucleotide ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/epidemiology ; Renal Insufficiency, Chronic/genetics ; Risk Assessment ; Genome-Wide Association Study
Language	English
Publishing date	2024-01-29
Publishing country	England
Document type	Journal Article
ZDB-ID	2160640-7
ISSN	1743-422X ; 1743-422X
ISSN (online)	1743-422X
ISSN	1743-422X
DOI	10.1186/s12985-023-02280-z
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

To top

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito